Early Treatment is Essential for Fighting Back Against Relapsed Mantle Cell Lymphoma
Source: pixabay.com

Early Treatment is Essential for Fighting Back Against Relapsed Mantle Cell Lymphoma

According to a December 9th press release from Janssen Biotech, Inc, the results of a pooled analysis of patients with mantle cell lymphoma illustrated that those treated with Imbruvica (ibrutinib) had…

Continue Reading Early Treatment is Essential for Fighting Back Against Relapsed Mantle Cell Lymphoma